Sara ReardonSara Reardon is a freelance journalist based in Bozeman, Mont. She is a former staff reporter at Nature, New Scientist and Science and has a master's degree in molecular biology. Popular weight-loss drug Wegovy now approved for heart disease. Here's what we know. The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works.
